Charles Morris

Charles Morris

Hoofd Techniek/Wetenschap/O&O bij PRELUDE THERAPEUTICS INCORPORATED
61 jaar
Health Technology
Consumer Services

Profiel

Charles Q.
Morris
is currently a Member at The Royal College of Physicians and Chief Medical Officer at Prelude Therapeutics, Inc. starting in 2026.
Former positions include Vice President-Worldwide Clinical Research at Cephalon, Inc., Chief Development Officer & Executive VP at ImmunoGen, Inc. from 2012 to 2016, Chief Medical Officer & Executive Vice President at Allos Therapeutics, Inc. from 2010 to 2012, Chief Medical Officer at Radius Health, Inc. from 2018 to 2020, Vice President-Clinical Development Projects at AstraZeneca Pharmaceuticals LP, Chief Development Officer at Akamis Bio Ltd. from 2016 to 2018, and Chief Medical Officer at Celyad Oncology SA from 2021 to 2023.
Education includes undergraduate studies at the University of Sheffield Medical School.

Actieve functies van Charles Morris

BedrijvenFunctieBegin
PRELUDE THERAPEUTICS INCORPORATED Hoofd Techniek/Wetenschap/O&O 20-04-2026
Corporate Officer/Principal 09-07-2010

Eerdere bekende functies van Charles Morris

BedrijvenFunctieEinde
LAVA THERAPEUTICS N.V. Hoofd Techniek/Wetenschap/O&O 01-10-2025
CELYAD ONCOLOGY SA Hoofd Techniek/Wetenschap/O&O 01-01-2023
RADIUS HEALTH, INC. Hoofd Techniek/Wetenschap/O&O 15-12-2020
Corporate Officer/Principal 01-09-2018
IMMUNOGEN, INC. Corporate Officer/Principal 02-09-2016
Ervaring van Charles Morris in detail bekijken

Opleiding van Charles Morris

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

63

Eerstegraads connecties

11

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit11

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

  1. Beurs
  2. Insiders
  3. Charles Morris
DE LAATSTE UREN | -40 %: De beste tools voorbehouden aan abonnees om de beste beleggingen van morgen te identificeren!
d
:
:
PROFITEER NU